Skip to main content
Springer Nature Link
Log in

T-cell abnormality and defective interleukin-2 production in patients with carcinoma of the urinary bladder with schistosomiasis

  • Original Articles
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Patients with schistosomiasis of the urinary bladder (SB) and schistosomiasis with carcinoma of the urinary bladder (SCB) had significantly increased percentage of IL-2R-, HLA-DR-, and transferrin receptor (T9)-bearing T cells in circulation. The percentage of these activated T cells decreased byin vitro culture with PHA but increased bySchistosoma haematobium soluble egg antigen. These patients with SB and SCB had a PHA-specific defect in IL-2 production. A functional defect with induction of IL-2R-positive suppressor monocytes appears to correlate with the defective PHA-induced IL-2 production by CD4+ T cells and monocytes. Disordered regulation of PHA-induced IL-2 production by the CD4+ T cells and monocytes may be the key feature in the highly depressed cell-mediated immune response in schistosomiasis. However, immune activation and significantly elevated IL-2 production in response to disease-specificS. haematobium soluble egg antigen may be related with the pathogenesis of SB and SCB. Thus,S. haematobium-specific CD4+ T cells are present in schistosomiasis, and their function is determined by adequate release of IL-2-and/or IL-2R-bearing CD11+ suppressor monocytes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Smithers SR, Doenhoff MI: Schistosomiasis.In Immunology of parasitic infections, S Cohen, KS Warren (eds). Blackwell Scientific, Oxford, 1982, p 527

    Google Scholar 

  2. Bloom BR: Games parasites play. How parasites evade immune surveillance. Nature 279:21–26, 1979

    Google Scholar 

  3. Sebai ZA: Schistosomiasis in Saudi Arabia. Ann Saudi Med 3:269–174, 1988

    Google Scholar 

  4. Ottesen EA: Modulation of the host response in human schistosomiasis. I. Adherent suppressor cells that inhibit lymphocyte proliferative response to parasite antigen. J Immunol 123:1639–1646, 1979

    Google Scholar 

  5. Capron A, Dessain JP: Effector and regulatory mechanism in immunity to schistosomiasis. A heuristic review. Annu Rev Immunol 3:455–476, 1985

    Google Scholar 

  6. Warren KS: Hepatosplenic schistosomiasis mansoni. An immunologic disease. Bull NY Acad Med 51:545–554, 1975

    Google Scholar 

  7. Warren KS: The secret of immunopathogenesis of schistosomiasis: In vivo models. Immunol Rev 61:189–213, 1982

    Google Scholar 

  8. Mahmoud AAF: Current concepts: Schistosomiasis. Med Intell 297:1329–1332, 1977

    Google Scholar 

  9. Ellner JJ, Olds GR, Kamel R, Osman GS, El-Kholy A: Mahmoud AAF: Suppressor splenic T lymphocytes in human hepatosplenic schistosomiasis mansoni. J Immunol 125:308–311, 1980

    Google Scholar 

  10. Abdel-Tawab GA, Kelada FS, Kelada NI: Studies on the etiology of bilharzial cancer of the urinary bladder. Int J Cancer 1:377–382, 1966

    Google Scholar 

  11. Ezzat E, Osman RA, Ahmed KY, Soothil JF: The association between schistosoma haematobium infection and heavy proteinurea. Trans Roy Soc Trop Med Hyg 68:315–318, 1974

    Google Scholar 

  12. Raziuddin S, Shetty S, Ibrahim A, Patil K: Activated CD4+ T lymphocytes and impaired cell mediated immunity in patients of carcinoma of the urinary bladder with schistosomiasis. Cancer 65:931–939, 1990

    Google Scholar 

  13. Boros DL, Warren KS: Delayed hypersensitivity type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from schistosoma mansoni eggs. J Exp Med 132:488–507, 1970

    Google Scholar 

  14. Carter CE, Colley DG: An electrophoretic analysis of schistosoma mansoni egg antigen preparation. J Parasitol 64:385–390, 1978

    Google Scholar 

  15. Raziuddin S, Hussain NK, Latif ABA: A monoclonal antibody and functional study of malignant T cells of a patient with suppressor T cell lymphoma. Clin Immunol Immunopathol 45:230–234, 1987

    Google Scholar 

  16. Wysocki L, Sato VL: Panning of lymphocytes. A method for cell selection. Proc Natl Acad Sci USA 75:2844–2847, 1978

    Google Scholar 

  17. Raziuddin S, Kibler RF, Morrison DC: Immunosuppression of experimental allergic encephalomyelitis. III.In vitro evidence for induction of suppressor T lymphocytes in lymph nodes of animals immunized with myelin basic protein complexed to lipopolysaccharides. J Immunol 128:2073–2080, 1982

    Google Scholar 

  18. Mittler R, Rao P, Olini G, Westberg E, Newman W, Goldstein G: Activated human B cells display a functional IL-2 receptor. J Immunol 134:2393–2397, 1985

    Google Scholar 

  19. Herrmann F, Cannistra SA, Levine H, Griffin JD: Expression of interleukin-2 receptors and binding of interleukin-2 by gamma interferon-induced human leukemic and normal monocytic cells. J Exp Med 162:1111–1116, 1985

    Google Scholar 

  20. Holter W, Grunow R, Stockinger H, Knapp W: Recombinant interferon-y induces interleukin 2 receptors on human peripheral blood lymphocytes. J Immunol 136:2171–2175, 1986

    Google Scholar 

  21. Smith KA: Interleukin 2. Annu Rev Immunol 2:319–333, 1984

    Google Scholar 

  22. Stobo JD: Immunosuppression in man: Suppression by macrophages can be mediated by interactions with regulatory T cells. J Immunol 119:918–923, 1977

    Google Scholar 

  23. Gazzinelli G, Lambertucci JR, Katz N, Rocha RS, Lima MS, Colley DG: Immune responses during human schistosomiasis mansoni. XI. Immunologic status of patients with acute infections and after treatment. J Immunol 135:2121–2127, 1985

    Google Scholar 

  24. Luft BJ, Pedrott PW, Remington JS: In vitro generation of adherent mononuclear cells to toxoplasma antigen. Immunology 63:643–648, 1988

    Google Scholar 

  25. Piessens WS, Rattiwanto S, Tuti S, Palmieri JK, Piessens PW, Koiman I, Dennis DT: Antigen specific suppressor cells and suppressor factors in human filariasis with brugia malayi. N Engl J Med 302:333–338, 1980

    Google Scholar 

  26. Peterson EA, Neva FA, Barral A, Lorrea-Cornas R, Bogaeart-Diaz H, Martinoz D, Ward EE: Monocyte suppression of antigen-specific response in diffuse cutaneous leishmaniasis patients from the Dominican Republic. J Immunol 132:2603–2611, 1984

    Google Scholar 

  27. Toosi Z, Kleinhenz ME, Ellner JJ: Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis. J Exp Med 163:1162–1172, 1986

    Google Scholar 

  28. Mohageghpour N, Gilber RH, Larrick JL, Sasaki DT, Bernnan PJ, Engleman EC: Defective cell mediated immunity in leprosy. Failure of T cells from leprosy patients to respond to mycobacterium leprae is associated with defective expression of IL-2 receptors and is not reconstituted by interleukin 2. J Immunol 135:1443–1449, 1985

    Google Scholar 

  29. Arno JN, Toosi Z, Edmonds K, Ellner JJ, Schmidt D: Decreased IL-2 production during reactivation of recurrent oral herpes simplex infection. Clin Res 32:363A, 1984 (abstr)

    Google Scholar 

  30. Harel-Bellan A, Joskowicz M, Eisen H: Modification of T cell proliferation and interleukin 2 production in mice infected with trypanosoma cruzi. Proc Natl Acad Sci USA 80:3466–3469, 1983

    Google Scholar 

  31. Reiner NE, Finke JH: Interleukin 2 deficiency in murine leishmaniasis donovani and its relationship to depressed spleen cell response to phytohemagglutinin. J Immunol 131:1487–1491, 1983

    Google Scholar 

  32. Kierszenbaum F, Bettz LA: Decreased human IL-2 receptor expression due to a protozoan pathogen. Immunol Today 10:129–131, 1989

    Google Scholar 

  33. Maizel AL, Ford RJ, Lachman LB: Effect of IL-1 on human thymocytes and human purified T cells. J Exp Med 155:943–952, 1981

    Google Scholar 

  34. Mizel SB: Interleukin 1 and T cell activation. Immunol Rev 63:51–69, 1982

    Google Scholar 

  35. Rappaport RS, Dodge G: Prostaglandin E inhibits the production of human interleukin 2. J Exp Med 155:943–952, 1982

    Google Scholar 

  36. Walker C, Kristensen F, Bettens F, DeWeck AL: Lymphokine regulation of activated lymphocytes. I. Prostaglandin E2 induced inhibition of interleukin 2 production. J Immunol 130:1770–1776, 1983

    Google Scholar 

  37. Chouaib S, Welte K, Mertelsmann R, Dupont B: Prostaglandin E2 acts at two distinct pathway of T lymphocyte activation. Inhibition of IL-2 and down regulation of transferrin receptor expression. J Immunol 135:1172–1179, 1985

    Google Scholar 

  38. Waldmann TA: The structure, function and expression of interleukin 2 receptors on normal and malignant lymphocytes. Science 232:727–732, 1986

    Google Scholar 

  39. Rosenberg SA: The adoptive therapy of cancer using the transfer of activated lymphoid cells and IL-2. Semin Oncol 13:200–216, 1986

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Immunology, and Department of Urology, King Saud University, College of Medicine, Abha, Saudi Arabia

    Syed Raziuddin, Sugandh Shetty & Ahmed Ibrahim

  2. Asir Central Hospital, Abha, Saudi Arabia

    Syed Raziuddin, Sugandh Shetty & Ahmed Ibrahim

Authors
  1. Syed Raziuddin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sugandh Shetty
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ahmed Ibrahim
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raziuddin, S., Shetty, S. & Ibrahim, A. T-cell abnormality and defective interleukin-2 production in patients with carcinoma of the urinary bladder with schistosomiasis. J Clin Immunol 11, 103–113 (1991). https://doi.org/10.1007/BF00917746

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00917746

Key words

Search

Navigation